News sentiment analysis powered by sentiment-insight.com
See The Luxury Homes CEOs And Founders Have Put On The Market This Year
Former Apple CEO Gil Amelio is selling his 14,000-square-foot home in the gated community of Reno's Montreux Golf & Country Club for $9.4 million. Bob Daly, former co-CEO of Warner Bros., has listed his 19-acre “Oaktree Ranch” for sale in Calabasas, California, for $24.9 million. Brent Saunders, the former CEO of Botox maker Allergan, listed a newly renovated waterfront mansion for $19.49 million.
Former Botox Executive Lists Waterfront Venetian Islands Estate In Miami For $19.5 Million Brent Saunders is the former CEO of Botox maker, Allergan, and the current CEO and chairman of eye health company Bausch + Lomb. The Venetian Islands are a chain of artificial islands in Biscayne Bay between Miami and Miami Beach.
Colorado receives another $270 million from national opioid settlements The Colorado Attorney General's Office announced Friday the final approval of $17.3 billion in national opioid agreements with drug makers Teva and Allergan and pharmacies CVS and Walgreens. Colorado will receive approximately $270 million over 15 years from these recent settlements. This money is in addition to the approximately $400 million Colorado has begun receiving from prior opioid settlements.
Governments get nearly $19 billion more in opioid lawsuit settlements The settlements are to be paid by drug manufacturers Allergan and Teva, plus CVS and Walgreens. Walmart is expected to finalize its deal shortly. In total, more than $50 billion has been allocated to settle waves of lawsuits.
Wisconsin lawmakers expected to accept settlement in opioid lawsuit A coalition of states and local governments secured settlements in November and December with opioid manufacturers Teva and Allergan as well as with pharmaceutical chains Walmart, Walgreens and CVS totaling $19.2 billion. Wisconsin is in line to receive about $324.3 million, with 30% going to the state and 70% to county governments.
UK antitrust partner leaves Kirkland for White & Case as enforcement heats up Michael Engel joins White & Case’s global antitrust group in London. Engel has advised on Fiat Chrysler-PSA merger, Bayer-Monsanto deal and Teva's acquisition of Allergan's generics business. Latham & Watkins, Dechert, Goodwin Procter and Proskauer all added antitrust partners in London this year.
Composite Artificial Skin Market Is Expected to Grow at a CAGR Of 4.8% during Forecast Period 2023 To 2030 | Data By Contrive Datum Insights Pvt Ltd. North America dominates the composite artificial skin market. Elderly, diabetic and obese populations are increasing in North America. Integra Life Sciences, Smith & Nephew, Organogenesis, MiMedx, Tissue Regenix, Mylan, Allergan.
Bausch + Lomb to name Brent Saunders as CEO – WSJ Bausch + Lomb Corp is expected to name Brent Saunders, the former chief executive of Allergan, as its CEO and chairman of the board.
Brent Saunders to return as Bausch + Lomb CEO Brent Saunders will join Bausch + Lomb on Feb. 16 in an advisory capacity. He will take helm on March 6 from Joseph Papa, who last July announced plans to step down as CEO. Saunders has served as the CEO of Botox maker Allergan.
Brent Saunders to return as Bausch + Lomb CEO Brent Saunders has served as the CEO of Botox maker Allergan, until it was acquired by AbbVie Inc (ABBV.N) for $63 billion in 2020. Saunders previously headed Bausch + Lomb until its acquisition by erstwhile Valeant in 2013.
Biosimilar Monoclonal Antibodies Global Market Report 2023 The global biosimilar monoclonal antibodies market is expected to grow from $4.51 billion in 2021 to $5.47 billion in 2022. Pfizer, Novartis, Allergan, Coherus BioSciences, Biocon, Amgen, Boehringer Ingelheim, Celltrion, BioXpress Therapeutics and Intas Pharmaceuticals Limited are major players.
Thousands of women warned their breast implants could cause deadly cancer... Allergan announced a global recall of Biocell textured breast implants in 2019. It came amid links to a fast-growing cancer called anaplastic large-cell lymphoma (ALCL) Many women have not been officially told of the risk they face.
Thousands of women warned their breast implants could cause deadly cancer... Allergan announced a global recall of Biocell textured breast implants in 2019. It came amid links to a fast-growing cancer called anaplastic large-cell lymphoma (ALCL) Many women have not been officially told of the risk they face.
Law firm Orrick hires arbitration group leader from rival in N.Y. Hagit Elul is joining San Francisco-founded Orrick's international arbitration practice. Elul will represent clients in the life sciences, energy and infrastructure, and technology sectors. Her clients have included Tokyo Electric Power Company, Bayer, Allergan and Merck.
Kansas to receive more than $45M in settlement money regarding opioid epidemic Teva and Allergan agreed to pay at least just over $28.4 million and $16.9 million, respectively. Teva has also agreed to quit lobbying for opioid products. Kansas has received $340 million in settlement from 11 defendants.
U-Haul ranks Georgia No. 8 growth state The Peach State will use the money from Allergan, CVS, Teva and Walgreens to help fund treatment, prevention, reduction. Georgia inspector general uncovers $6.7M in fraudulent payments to state employees.
Oklahoma reaches 4 new opioid settlements totaling more than $226 million Oklahoma reaches settlements with drugmaker Allergan and pharmacy chains CVS, Walgreens and Walmart. Oklahoma has received more than $900 million from opioid makers and distributors to help address the state's opioid crisis.
Sign Up
